Free shipping on all orders over $ 500
  Catalog
Abmole Inhibitor Catalog 2017

p38 MAPK P38 mitogen-activated protein kinases

Inhibitors

Cat.No.  Name Information
M5873 Pexmetinib (ARRY-614) Pexmetinib (ARRY-614) is a potent, orally bioavailable, dual p38 MAPK/Tie-2 inhibitor with IC50 of 4 nM/18 nM in a HEK-293 cell line. Phase 1.
M3751 Losmapimod Losmapimod (GW856553) is a selective, potent, and orally active p38 MAPK inhibitor with pKi of 8.1 and 7.6 for p38α and p38β, respectively.
M3294 VX-745 VX-745 is a potent and selective inhibitor of p38α with IC50 of 10 nM, 22-fold greater selectivity versus p38β and no inhibition to p38γ.
M3048 TAK-715 TAK-715 is a p38 MAPK inhibitor for p38α with IC50 of 7.1 nM, 28-fold more selective for p38α over p38β, no inhibition to p38γ/δ, JNK1, ERK1, IKKβ, MEKK1 or TAK1.
M3011 Skepinone-L Skepinone-L is a selective p38α-MAPK inhibitor with IC50 of 5 nM.
M2583 PD 169316 PD 169316 is a potent, cell-permeable and selective p38 MAP kinase inhibitor with IC50 = 89 nM.
M2318 LY2228820 LY2228820 is a novel and potent inhibitor of p38 MAPK with IC50 of 7 nM.
M2317 VX-702 VX-702 is a highly selective inhibitor of p38 MAPKα with IC50 of 4-20 nM.
M2136 PH-797804 PH-797804 is a highly selective and potent inhibitor of p38 MAP kinase with IC50 of 26 nM.
M2062 SB 202190 SB 202190 is a highly selective, potent and cell permeable inhibitor of p38 MAP kinase with IC50 values of 50 and 100 nM inhibiting p38α and p38β, respectively.
M1781 SB203580 SB203580 inhibits the IL-2-induced proliferation of primary human T cells, murine CT6 T cells, or BAF F7 B cells with an IC50 of 3-5 μM.
M1675 BIRB796 BIRB 796 (Doramapimod) is a protein kinase inhibitor of p38 MAPK with Kd of 100pM.

Get to Know Us
Customer Support
Resources
Contact Us
  • Tel: +1-800-660-8580
  • Email: [email protected]
  • Tel: +32 (0)2 738 09 61
  • Email: [email protected]

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2017 AbMole BioScience. All Rights Reserved.